223 related articles for article (PubMed ID: 28183077)
1. Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards.
Garland EL; Howard MO; Zubieta JK; Froeliger B
Psychother Psychosom; 2017; 86(2):111-112. PubMed ID: 28183077
[No Abstract] [Full Text] [Related]
2. Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement.
Garland EL; Atchley RM; Hanley AW; Zubieta JK; Froeliger B
Sci Adv; 2019 Oct; 5(10):eaax1569. PubMed ID: 31663023
[TBL] [Abstract][Full Text] [Related]
3. Disrupting the downward spiral of chronic pain and opioid addiction with mindfulness-oriented recovery enhancement: a review of clinical outcomes and neurocognitive targets.
Garland EL
J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):122-9. PubMed ID: 24845547
[TBL] [Abstract][Full Text] [Related]
4. Treating chronic pain: the need for non-opioid options.
Garland EL
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):545-50. PubMed ID: 24918159
[TBL] [Abstract][Full Text] [Related]
5. The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.
Garland EL; Froeliger B; Zeidan F; Partin K; Howard MO
Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2597-607. PubMed ID: 23988582
[TBL] [Abstract][Full Text] [Related]
6. Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity.
Garland EL; Froeliger B; Howard MO
Psychopharmacology (Berl); 2014 Aug; 231(16):3229-38. PubMed ID: 24595503
[TBL] [Abstract][Full Text] [Related]
7. Thinking About Patients in Pain.
Kennedy MS
Am J Nurs; 2016 Jul; 116(7):7. PubMed ID: 27336967
[TBL] [Abstract][Full Text] [Related]
8. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
[TBL] [Abstract][Full Text] [Related]
9. Allostatic dysregulation of natural reward processing in prescription opioid misuse: autonomic and attentional evidence.
Garland EL; Froeliger B; Howard MO
Biol Psychol; 2015 Feb; 105():124-9. PubMed ID: 25603284
[TBL] [Abstract][Full Text] [Related]
10. Mindfulness-Based Therapy Reduces Chronic Pain and Opioid Misuse.
Slomski A
JAMA; 2022 May; 327(17):1641. PubMed ID: 35503359
[No Abstract] [Full Text] [Related]
11. Opioid analgesic dependence: where do we go from here?
Quinlan J; Alam F; Knox K
Br J Gen Pract; 2017 Apr; 67(657):154-155. PubMed ID: 28360045
[No Abstract] [Full Text] [Related]
12. [Not Available].
Schneider T; Ruppen W
Ther Umsch; 2017; 74(5):277-283. PubMed ID: 29083286
[No Abstract] [Full Text] [Related]
13. Where now for opioids in chronic pain?
Stannard C
Drug Ther Bull; 2018 Oct; 56(10):118-122. PubMed ID: 30254063
[No Abstract] [Full Text] [Related]
14. Opioids and chronic pain in primary care.
Brinksman S
Br J Gen Pract; 2018 Oct; 68(675):454-455. PubMed ID: 30262604
[No Abstract] [Full Text] [Related]
15. Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards.
Garland EL; Fix ST; Hudak JP; Bernat EM; Nakamura Y; Hanley AW; Donaldson GW; Marchand WR; Froeliger B
Psychol Med; 2023 Apr; 53(5):2085-2094. PubMed ID: 37310337
[TBL] [Abstract][Full Text] [Related]
16. Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients.
Garland EL; Bryan CJ; Finan PH; Thomas EA; Priddy SE; Riquino MR; Howard MO
Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S65-S72. PubMed ID: 28363322
[TBL] [Abstract][Full Text] [Related]
17. Combating the increase in opioid misuse.
Nolan W; Gannon R
Conn Med; 2013 Sep; 77(8):495-8. PubMed ID: 24156180
[No Abstract] [Full Text] [Related]
18. Risk factors and screening for opioid misuse: current clinical implications for prescription opioid therapy.
Hah J
Pain Manag; 2021 Nov; 11(6):625-630. PubMed ID: 34155912
[No Abstract] [Full Text] [Related]
19. Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.
Hale ME; Moe D; Bond M; Gasior M; Malamut R
Pain Manag; 2016 Oct; 6(5):497-508. PubMed ID: 27050830
[TBL] [Abstract][Full Text] [Related]
20. Opiod Misuse, Abuse and Addiction Part 2: Opiod Prescriber Responsibilities and Resources.
Paul SM; Allread V
MD Advis; 2017; 10(1):4-16. PubMed ID: 28586557
[No Abstract] [Full Text] [Related]
[Next] [New Search]
